<!DOCTYPE html>
<html lang="ko">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>생-32 | 2021_서울대_생명과학_문제1</title>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
<style>
@font-face {
  font-family: 'SamsungKin';
  src: url('https://ntgpabdgdzwheoykftou.supabase.co/storage/v1/object/public/interview-pdfs/html-assets/fonts/SamsungKin-Light.ttf') format('truetype');
  font-weight: 300;
}
@font-face {
  font-family: 'SamsungKin';
  src: url('https://ntgpabdgdzwheoykftou.supabase.co/storage/v1/object/public/interview-pdfs/html-assets/fonts/SamsungKin-Medium.ttf') format('truetype');
  font-weight: 500;
}
@font-face {
  font-family: 'SamsungKin';
  src: url('https://ntgpabdgdzwheoykftou.supabase.co/storage/v1/object/public/interview-pdfs/html-assets/fonts/SamsungKin-Bold.ttf') format('truetype');
  font-weight: 700;
}

@page {
  size: A4;
  margin: 31mm 0 16mm 0;
}
* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}
body {
  font-family: 'SamsungKin', 'Malgun Gothic', sans-serif;
  font-weight: 500;
  font-size: 10.5pt;
  line-height: 1.75;
  color: #1a1a1a;
  background: white;
}

.header {
  position: fixed;
  top: 0;
  left: 0;
  right: 0;
  height: 28mm;
  padding: 8mm 20mm 0 20mm;
  display: flex;
  justify-content: space-between;
  align-items: flex-end;
  z-index: 100;
  background: white;
}
.header img {
  height: 12mm;
  margin-bottom: 2mm;
}
.header .header-text {
  font-size: 9pt;
  font-weight: 500;
  color: #666;
  letter-spacing: 0.5px;
  margin-bottom: 2mm;
}
.header-line {
  position: fixed;
  top: 28mm;
  left: 20mm;
  right: 20mm;
  border-bottom: 2px solid #003366;
  z-index: 100;
}

.footer {
  position: fixed;
  bottom: 0;
  left: 0;
  right: 0;
  height: 14mm;
  padding: 0 20mm;
  background: white;
  z-index: 100;
}
.footer-line {
  border-top: 1px solid #003366;
  margin-bottom: 2mm;
}
.footer-text {
  text-align: center;
  font-size: 9pt;
  font-weight: 500;
  color: #003366;
}

.content {
  padding: 33mm 20mm 18mm 20mm;
}
.main-title {
  font-family: 'SamsungKin', sans-serif;
  font-size: 20pt;
  font-weight: 700;
  color: #003366;
  margin-bottom: 10px;
}
.sub-title {
  font-family: 'SamsungKin', sans-serif;
  font-size: 13pt;
  font-weight: 700;
  color: #003366;
  margin-top: 20px;
  margin-bottom: 6px;
  padding-bottom: 4px;
  border-bottom: 2.5px solid #003366;
  display: inline-block;
  min-width: 50px;
}
.question-block {
  break-inside: avoid;
  page-break-inside: avoid;
  margin-bottom: 6px;
}
p {
  margin-bottom: 5px;
  text-align: justify;
  word-break: keep-all;
}
.spacer {
  height: 3px;
}
.sub-question {
  margin-top: 12px;
  margin-bottom: 4px;
}
.sq-num {
  font-weight: 700;
  color: #003366;
  margin-right: 3px;
}
.figure {
  text-align: center;
  margin: 14px 0;
  break-inside: avoid;
  page-break-inside: avoid;
}
.figure img {
  max-width: 70%;
  max-height: 240px;
}
.figure-row {
  display: flex;
  justify-content: center;
  gap: 10px;
  margin: 14px 0;
  break-inside: avoid;
  page-break-inside: avoid;
}
.figure-row img {
  max-width: 48%;
  max-height: 240px;
  object-fit: contain;
}
.md-table {
  width: 100%;
  border-collapse: collapse;
  margin: 12px 0;
  font-size: 9.5pt;
  break-inside: avoid;
}
.md-table th, .md-table td {
  border: 1px solid #ccc;
  padding: 4px 8px;
  text-align: center;
}
.md-table th {
  background: #f0f4f8;
  font-weight: 700;
  color: #003366;
}
.passage-box {
  background: #f8f9fb;
  border-left: 3px solid #003366;
  padding: 10px 14px;
  margin: 8px 0;
  border-radius: 0 4px 4px 0;
}
.passage-box p {
  margin-bottom: 5px;
}
.passage-box .spacer {
  height: 2px;
}
.passage-box .figure {
  margin: 10px 0;
}
.passage-box .md-table {
  margin: 8px 0;
}
.passage-marker {
  font-weight: 700;
  color: #003366;
}
.ai-disclaimer {
  background: #FFF9C4;
  border-left: 4px solid #F9A825;
  padding: 8px 14px;
  margin: 10px 0;
  font-size: 9pt;
  font-style: italic;
  color: #5D4037;
  border-radius: 0 4px 4px 0;
}
.katex {
  font-size: 1.05em;
}
.math-block {
  margin: 10px 0;
  text-align: center;
}

@media print {
  .content {
    padding: 2mm 20mm 0 20mm;
  }
  .header, .footer {
    position: fixed;
  }
  .question-block, .figure {
    break-inside: avoid;
    page-break-inside: avoid;
  }
  .no-print {
    display: none !important;
  }
}

</style>
</head>
<body>

<div class="header">
  <img src="https://ntgpabdgdzwheoykftou.supabase.co/storage/v1/object/public/interview-pdfs/html-assets/logo.png" />
  <span class="header-text">과학 면접 아카데미 &nbsp;|&nbsp; 생명과학</span>
</div>
<div class="header-line"></div>

<div style="text-align:right;padding:4px 20mm 0;"><a href="생-32-해설.html" class="sol-link" style="color:#003366;font-size:9pt;text-decoration:none;">해설 보기 &rarr;</a></div>
<div class="content">
  <div class="question-block">
<h1 class="main-title">문제 1</h1>
<div class="spacer"></div>
<p>사람의 필수 영양소인 비타민 C는 포도당으로부터 합성되며, 과일과 채소에 풍부하게 함유되어있다. 식물 뿐 아니라 쥐, 소, 개, 돼지, 닭 등을 포함한 대부분의 동물들도 비타민 C 합성과정에 필요한 효소를 갖고 있다. 하지만 과일과 채소를 주식으로 하는 과일박쥐와 기니피그는 비타민 C를 합성하지 못한다. 또한 대부분의 영장류도 비타민 C를 합성하지 못하기 때문에 음식을 통해 섭취해야 한다.</p>
<div class="spacer"></div>
<p>다음 과정을 통해 사람이 비타민 C를 합성할 수 없게 된 진화적 근거를 유추해보고자 한다.</p>
<div class="spacer"></div>
<p>모든 동물의 비타민 C 합성 경로가 다음과 같이 알려졌다.</p>
<div class="spacer"></div>
<div class="figure"><img src="data:image/png;base64,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" /></div>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-1</h2>
<div class="spacer"></div>
<p>사람이 어떤 이유 때문에 비타민 C를 합성할 수 없는지 알아보기 위해 다음과 같은 가설을 설정하였다. "사람은 '효소1~4' 중 어떤 한 효소의 기능결함으로 인해 비타민 C를 합성하지 못한다."</p>
<div class="spacer"></div>
<p>다음 실험 재료를 사용하여 위 가설이 맞는지 검증하기 위한 실험을 설계하고, 각각의 효소에 결함이 있을 때 예상되는 결과를 설명하시오.</p>
<div class="spacer"></div>
<p>재료: 사람 체세포, 포도당, 전구 물질 A, 전구 물질 B, 전구 물질 C, 배지</p>
<div class="spacer"></div>
<p>(단, 배양된 사람 체세포는 포도당과 전구 물질들을 세포내로 수송한다).</p>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-2</h2>
<div class="spacer"></div>
<p>문제 1-1과 같은 실험과 염기 서열 분석을 통해 비타민 C를 합성하지 못하는 모든 동물에서 '효소4' 유전자의 일부가 소실되어 '효소4'가 기능하지 않는다는 사실을 확인하였다. 일반적으로 물질대사 과정의 전구 물질들이 여러 다른 물질대사 과정에도 사용될 수 있다. 이를 고려하여, '효소1~3' 각각의 유전자 소실과 '효소4'의 유전자 소실이 세포의 물질 대사에 미칠 파급효과를 비교하시오.</p>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-3</h2>
<div class="spacer"></div>
<p>아래 그림은 사람과 종 A~C의 계통수와 각 종에 속하는 모든 개체의 비타민 C 합성여부를 나타낸 것이다. 각각의 종으로 구성된 개체군 집단은 멘델 집단이다. (그림에서 'O'는 비타민 C 합성 가능을, 'X'는 비타민 C 합성 불가능을 의미한다.)</p>
<div class="spacer"></div>
<div class="figure"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAW4AAAD8CAIAAADYGdkkAAAACXBIWXMAAA7EAAAOxAGVKw4bAAAJ1UlEQVR4nO3dUZLbuA4F0Ows2VkvLUuYJfWbqrxxhd0SRUuQCEjn/I0t2gAF3qiTTOXHJ8BhP2YXANyBKAECiBIggCgBAogSIIAoAQKIEiCAKAECiBIggCiBU/z4z5Vrj3zpQaIEznLkVB+MoX1feoQogRjfnwjWTvWPrs7azVWdLx0s4+22X5+2eyU82eLZGz/Vm+e2H0P7vnRzlSiBCepGyfiHjxMlsJMoadbuWwYcj5LvNtcej5IjedH72PBPhIfYHQf9t/oXiBK4m+NPJZsfPhJPogRquyBK1l7f9yg0eME+ogR2OilKFgPiSFXvXrCPKIGdYqPkS4KcFyWda46kjCiBnY78rNFf2F/79/K1t0Yq37d29TP3LQM2HTqZJ/+c8m54bX/g7pVAX+Yo+Vx6Mjr0aUcWAx3JoyRWolLgZi6Iko5937ubKAECiBIggCgBAogSIIAoAQKIEiCAKIETHfmj2d1rp/x5sCiBAJ2/0zF4qo+sXfu08S/afGv7G3esAcaNH85roqT/riiBCUb+yulbTyUjLy5+9fjCkY/drHZh4Y41wLi3ouT379+LedT/zHcfZ0YS8F2iBAJ0juLIKf37gn/++efL64sX9wsYiZJ33+oTJXBU/xlh83D+fcHI2pEXRQnUcyRK1p5iOmujoqRjtdV1ogSO2h0la2+9Xj8pSs4gSiBA51f1zbzY/NjxF48/XOwmSiCp15/mfH9r8xlkPG76xqsVJRBg7ey9dSa/n+R/02Tw4sV33yp+8OLVDzm4Hvhj8AlifPmREy5KoKojPykcjKGDC0UJJHIkDkQJ8H9Hnko+/YAD/HH8yWJHAL1bzPGLVz/k4HqAT1EChBAlQABRAgQQJUAAUQIEECVAAFECBBAlQABRAgQQJUAAUQIEECVAAFECBBAlQABRAgQQJUAAUQIEECVAAFECBBAlQABRAgQQJZRx5F+Z4WzuAQUspsZDoqRKbiYtC176Ryjz6Tou9p/sO1XGmuBl5JfitKfroOP/3N+V0hUEfxMl46/PdUVBHx8fnd8w47G2p3P4yvvpN55wW0QJ02xP5/CV99NvPOG2iBKm2Z7O4Svvp994wm0RJUyzPZ3DV95Pv/GE2yJKmGZ7OoevvJ9+4wm3RZQwzfZ0Dl95S2u959wTUcI029M5fOUtrfWec08uKmjfJMHItNx4nL63lrZZUUJqD4+ST/8PztevESXs1R8Y45SEKKGAtbExS3mIEspYnCKDlIQoAQKIEiCAKAECiBIggCgBAogSIIAoAQKIEiCAKAECiBIggCgBAogSIIAoAQKIEiCAKAECiBIggCgBAogSIIAoAQKIEiCAKAECiBIggCgBAogSIIAoAQKIEiCAKAECiBIggCgBAogSIIAoAQL8+Pj4WDznF5jdOxBGlAABRAkQQJRAalUOjighKSP0+d8m9F9JQpSQ2tq0PGGK1hrM2bgoIbXOtNx+kPqNX19Pn79XQmr9abnxLPX7Sti1KCE1UbLj3SlESWPij3tP8+9Wj9yR1/U73i2t31fCrkVJQ5RcRpT09ftK2LUoaYiSyxyPks5bN9BvLWHjoqTx8+fP084OjXejZM3JEzHTWoM5GxcljahzwiZPJZv6jV9fT58oaZx2cPjK75WM+N5d2n5FSeO0g8NXIVEyckF137dudkXLREmjSp3PIUqqECWNKnU+hyipQpQ0qtT5HP274B7lIUoaVep8jrW74AZlI0oaVep8gsV74dakJUoaVeqEbERJo0qdkI0oaVSpE7IRJY0qdUI2oqRRpU7IRpQ0qtQJ2YiSRpU6IRtR0qhSJ2QjShpV6oRsREmjSp2QjShpVKkTshEljSp1QjaipFGlTshGlDSq1AnZiJJGlTohG1HSqFInZCNKGlXqhGxESaNKnZCNKGlUqROyESWNKnVCNqKkUaVOyEaUNKrUCdmIkkaVOiEbUdKoUidkI0oaVeqEbGZGSRXXbBGUJkq2XbNFUJoo2XbNFkFpomTbNVsEpYmSbddsEZQmSrZds0UMcl9yuuh+/Pz5c2IWHHTNFjHIfcnJ/WiIkuSedl8KTWPeyqYQJck96tZ87zFz10nLmkWUZPaoW7PWYNrGM9Y0kSjJ7O/bcfu7I0pqEyWZPSdK+q3lbDxdQXMVipKPj4/Fakv49evXu/2+1i7+5830W8vZeLqC5lqc+9lFLSv95+u7o+T7Kz+y3qAj+n3l7DpdQXMtzv3sopadedJP926UvBZuvngP/b5ydp2uoLkW5352UctOO+ZX2B0li07a4Yn6feXsOl1BcxWa1MCDfb19UdLZhKBNTaTf8vX1bMpY00SLcz+7qGVnnvTTvRUlr1VvvVVdv+Xr69mUsaaJFud+dlHLTjvmV9gRJf1NCNrUXL63lrnZpGXNsjj3s4taVqjUIzZbu3Hvn6X+gm/eyqYodD4LlXrEZl837r0WN6BR6HwWKnWfze5uvwO12PpGoeksVCpPYPgahc5noVJ5AsPXKHQ+C5XKExi+RqHzWahUnsDwNQqdz0Kl8gSGr1HofBYqlScwfI1C57NQqTyB4WsUOp+FSuUJDF+j0PksVCpPYPgahc5noVJ5AsPXKHQ+C5XKExi+xuL5LGT2/vFchq8xOwqOmr1/PJfha8yOgqNm7x/PZfgas6PgqNn7x3MZvsbsKDhq9v7xXIavMTsKjpq9fzyX4WuU/ifvfogS5jF8VYkSUjF8VYkSUjF8VYkSUjF8VYkSUjF8VYkSUjF8VYkSUjF8VYkSUjF8VYmSLwK3wq7uYJuqEiWLArfCrr7FNlUlShatbcXidvU30K6+xTZV9dgo6Te7Yys202d/rU9im6p6bJR8dg+5KJnFNlUlSm4cJWu3NfPtzlUN40TJW1GyuF393Zu+q52qptTTl7EmRoycjbR+/fp1vPHwd0d2eHfZOyx+4/VlDMpYEyPiz/eFakXJ7lKP+1LA9Ho6kpbFpnPP+skyR8n3aneXGuJVQ4ZiOvJWRt8pR/wqu6Pk9Qlvbcvm8sXrN7/rGq8aMhTTkbcy+kKO9CzHo+SPzgU7Nu2tj7pSnko6UhdHR8SJnmZflLyWfw48Xwzu2+bX7agz1peWZ5ezKm9l9J1xwi+zI0peazuvrL1Y2qud5H3lrQxe1gJiMF/qWuxuYj0dScuCl346fHl3MEreeoYK7mdYJz2n1NOXsSZ4GTnPO6Jk5GJR8paMNcEfO47NPaJk7bEoyePSolzVwEH3iJKKbBO3IkpmsU3cSniUhFZ3Z3aKW9kXJX1n13wPtolbeevwS4pA9hEIIEqAAKIECCBKgACiBAggSoAAogQIIEqAAKIECCBKgACiBAggSoAAogQIIEqAAKIECCBKgAD/A6uA+cx246WqAAAAAElFTkSuQmCC" /></div>
<div class="spacer"></div>
<p>하디-바인베르크 법칙을 설명하고, 비타민 C를 합성하는 형질이 정상 대립유전자 G와 비정상 대립유전자 g에 의해 결정된다고 할 때, 각 개체군에서 대립유전자 G와 g의 각 빈도 p, q를 구하시오. (단, 대립유전자 G가 하나만 존재해도 '효소4'는 정상기능을 한다.)</p>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-4</h2>
<div class="spacer"></div>
<p>비타민 C를 합성하는 생물과 비교했을 때, '효소4'의 소실로 인해 비타민 C를 합성하지 못하는 생물이 가질 수 있는 이점을 포도당의 용도를 고려하여 추론하시오.</p>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-5</h2>
<div class="spacer"></div>
<p>비타민 C를 생성하지 못하는 종의 종분화 과정을 유전자풀의 변화 요인에 근거하여 유추하시오.</p>
<div class="spacer"></div>
</div>
<div class="question-block">
<h2 class="sub-title">1-6</h2>
<div class="spacer"></div>
<p>"어떤 영양소가 풍부한 환경에서는 이것을 합성하지 못하는 종이 생존에 더 유리할 수 있다"는 가설을 검증하기 위해 아미노산인 트립토판을 합성하지 못하는 대장균(트립토판 영양 요구주)을 이용하여 실험을 해보고자 한다. 트립토판은 세포내에서 포도당과 질소원으로부터 여러 개의 효소를 이용하여 합성된다. 야생형과 트립토판 영양 요구주 중에서 어떤 것이 생존경쟁에 유리한지를 확인하는 실험을 설계하시오.</p>
<div class="spacer"></div>
</div>
</div>

<div class="footer">
  <div class="footer-line"></div>
  <div class="footer-text">생-32</div>
</div>

<script src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js"></script>
<script>
  document.addEventListener("DOMContentLoaded", function() {
    renderMathInElement(document.body, {
      delimiters: [
        {left: "\\[", right: "\\]", display: true},
        {left: "\\(", right: "\\)", display: false},
        {left: "$$", right: "$$", display: true},
        {left: "$", right: "$", display: false}
      ],
      throwOnError: false
    });
  });
</script>
</body>
</html>